Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials

Collard, Harold R., Yow, Eric, Richeldi, Luca, Anstrom, Kevin J. and Glazer, Craig (2013) Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials. Respiratory Research, 14, 73. (doi:10.1186/1465-9921-14-73). (PMID:23848435)

Abstract

In this study one half of respiratory serious adverse events were attributed to definite or suspected acute exacerbations. Suspected acute exacerbations are clinically indistinguishable from definite acute exacerbations and represent clinically meaningful events. Clinical trialists should consider capturing both definite and suspected acute exacerbations as outcome measures.

This record has no associated files available for download.

Contributors

Download statistics